Kindred Healthcare, Inc. (KND) Expected to Post Quarterly Sales of $1.46 Billion

Equities research analysts predict that Kindred Healthcare, Inc. (NYSE:KND) will announce sales of $1.46 billion for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Kindred Healthcare’s earnings. Kindred Healthcare reported sales of $1.79 billion in the same quarter last year, which would suggest a negative year over year growth rate of 18.4%. The firm is expected to report its next earnings results after the market closes on Monday, November 6th.

On average, analysts expect that Kindred Healthcare will report full year sales of $1.46 billion for the current fiscal year, with estimates ranging from $5.98 billion to $6.02 billion. For the next year, analysts anticipate that the company will report sales of $6.04 billion per share, with estimates ranging from $6.02 billion to $6.06 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Kindred Healthcare.

Kindred Healthcare (NYSE:KND) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $0.38 earnings per share. The business’s revenue was down 4.6% compared to the same quarter last year.

KND has been the subject of several recent research reports. Zacks Investment Research raised Kindred Healthcare from a “sell” rating to a “hold” rating in a report on Friday, August 11th. BidaskClub lowered Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Deutsche Bank AG lowered their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating for the company in a report on Monday, August 7th. Bank of America Corporation lowered their target price on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating for the company in a report on Thursday, September 21st. Finally, Mizuho reaffirmed a “neutral” rating and set a $7.50 target price (down from $8.00) on shares of Kindred Healthcare in a report on Tuesday. Six analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $8.75.

Hedge funds and other institutional investors have recently modified their holdings of the company. Janus Henderson Group PLC acquired a new position in shares of Kindred Healthcare during the second quarter worth approximately $130,000. Amalgamated Bank boosted its position in shares of Kindred Healthcare by 0.9% during the second quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock worth $134,000 after buying an additional 108 shares during the period. Point72 Asia Hong Kong Ltd acquired a new position in shares of Kindred Healthcare during the first quarter worth approximately $121,000. Two Sigma Securities LLC boosted its position in shares of Kindred Healthcare by 54.5% during the first quarter. Two Sigma Securities LLC now owns 15,632 shares of the health services provider’s stock worth $131,000 after buying an additional 5,511 shares during the period. Finally, Paloma Partners Management Co acquired a new position in shares of Kindred Healthcare during the first quarter worth approximately $133,000. Institutional investors and hedge funds own 88.14% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Kindred Healthcare, Inc. (KND) Expected to Post Quarterly Sales of $1.46 Billion” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2017/10/13/kindred-healthcare-inc-knd-expected-to-post-quarterly-sales-of-1-46-billion.html.

Kindred Healthcare (NYSE:KND) traded down 2.44% during mid-day trading on Tuesday, reaching $6.00. The company’s stock had a trading volume of 3,775,537 shares. Kindred Healthcare has a 12-month low of $5.50 and a 12-month high of $11.90. The firm’s 50 day moving average price is $6.99 and its 200 day moving average price is $8.99. The stock’s market cap is $522.11 million.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply